Cargando…

Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms

Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Zarepour, Atefeh, Hooshmand, Sara, Gökmen, Aylin, Zarrabi, Ali, Mostafavi, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620694/
https://www.ncbi.nlm.nih.gov/pubmed/34831412
http://dx.doi.org/10.3390/cells10113189
_version_ 1784605282229288960
author Zarepour, Atefeh
Hooshmand, Sara
Gökmen, Aylin
Zarrabi, Ali
Mostafavi, Ebrahim
author_facet Zarepour, Atefeh
Hooshmand, Sara
Gökmen, Aylin
Zarrabi, Ali
Mostafavi, Ebrahim
author_sort Zarepour, Atefeh
collection PubMed
description Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote functional repair after SCI. Several experimental approaches have been explored to tackle SCI, including the combination of stem cells and 3D bioprinting. Implanted multipotent stem cells with self-renewing capacity and the ability to differentiate to a diversity of cell types are promising candidates for replacing dead cells in injured sites and restoring disrupted neural circuits. However, implanted stem cells need protection from the inflammatory agents in the injured area and support to guide them to appropriate differentiation. Not only are 3D bioprinted scaffolds able to protect stem cells, but they can also promote their differentiation and functional integration at the site of injury. In this review, we showcase some recent advances in the use of stem cells for the treatment of SCI, different types of 3D bioprinting methods, and the combined application of stem cells and 3D bioprinting technique for effective repair of SCI.
format Online
Article
Text
id pubmed-8620694
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86206942021-11-27 Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms Zarepour, Atefeh Hooshmand, Sara Gökmen, Aylin Zarrabi, Ali Mostafavi, Ebrahim Cells Review Spinal cord injury (SCI) has a major impact on affected patients due to its pathological consequences and absence of capacity for self-repair. Currently available therapies are unable to restore lost neural functions. Thus, there is a pressing need to develop novel treatments that will promote functional repair after SCI. Several experimental approaches have been explored to tackle SCI, including the combination of stem cells and 3D bioprinting. Implanted multipotent stem cells with self-renewing capacity and the ability to differentiate to a diversity of cell types are promising candidates for replacing dead cells in injured sites and restoring disrupted neural circuits. However, implanted stem cells need protection from the inflammatory agents in the injured area and support to guide them to appropriate differentiation. Not only are 3D bioprinted scaffolds able to protect stem cells, but they can also promote their differentiation and functional integration at the site of injury. In this review, we showcase some recent advances in the use of stem cells for the treatment of SCI, different types of 3D bioprinting methods, and the combined application of stem cells and 3D bioprinting technique for effective repair of SCI. MDPI 2021-11-16 /pmc/articles/PMC8620694/ /pubmed/34831412 http://dx.doi.org/10.3390/cells10113189 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Zarepour, Atefeh
Hooshmand, Sara
Gökmen, Aylin
Zarrabi, Ali
Mostafavi, Ebrahim
Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title_full Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title_fullStr Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title_full_unstemmed Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title_short Spinal Cord Injury Management through the Combination of Stem Cells and Implantable 3D Bioprinted Platforms
title_sort spinal cord injury management through the combination of stem cells and implantable 3d bioprinted platforms
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620694/
https://www.ncbi.nlm.nih.gov/pubmed/34831412
http://dx.doi.org/10.3390/cells10113189
work_keys_str_mv AT zarepouratefeh spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms
AT hooshmandsara spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms
AT gokmenaylin spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms
AT zarrabiali spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms
AT mostafaviebrahim spinalcordinjurymanagementthroughthecombinationofstemcellsandimplantable3dbioprintedplatforms